Yi Ching Yau - Net Worth and Insider Trading
Yi Ching Yau Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Yi Ching Yau owns 2 companies in total, including BridgeBio Pharma Inc (BBIO) , and ChemoCentryx Inc (CCXI) .
Click here to see the complete history of Yi Ching Yau’s form 4 insider trades.
Insider Ownership Summary of Yi Ching Yau
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
BBIO | BridgeBio Pharma Inc | 2019-10-09 | Chief Accounting Officer |
CCXI | ChemoCentryx Inc | 2022-06-06 | SVP & Finance & Acctg Officer |
Yi Ching Yau Trading Performance
Yi Ching Yau Ownership Network
Yi Ching Yau Owned Company Details
What does BridgeBio Pharma Inc do?
Who are the key executives at BridgeBio Pharma Inc?
Yi Ching Yau is the Chief Accounting Officer of BridgeBio Pharma Inc. Other key executives at BridgeBio Pharma Inc include 10 percent owner Kkr Genetic Disorder L.p. , director & See Remarks Neil Kumar , and See Remarks Brian C Stephenson .
BridgeBio Pharma Inc (BBIO) Insider Trades Summary
Over the past 18 months, Yi Ching Yau made no insider transaction in BridgeBio Pharma Inc (BBIO). Other recent insider transactions involving BridgeBio Pharma Inc (BBIO) include a net sale of 422,045 shares made by Neil Kumar , a net sale of 194,376 shares made by Brian C Stephenson , and a net sale of 12,000 shares made by Randal W Scott .
In summary, during the past 3 months, insiders sold 5,831,544 shares of BridgeBio Pharma Inc (BBIO) in total and bought 0 shares, with a net sale of 5,831,544 shares. During the past 18 months, 8,037,166 shares of BridgeBio Pharma Inc (BBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 8,037,166 shares.
BridgeBio Pharma Inc (BBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
BridgeBio Pharma Inc Insider Transactions
Yi Ching Yau Mailing Address
Above is the net worth, insider trading, and ownership report for Yi Ching Yau. You might contact Yi Ching Yau via mailing address: C/o Bridgebio Pharma, Inc., 421 Kipling Street, Palo Alto Ca 94301.